In this study, we expand our observations of Id4 expression in established prostate cancer cell lines and prostate cancer tissue to demonstrate that Id4 expression is decreased in prostate cancer due to promoter hypermethylation. This evidence concerns the gene ID4 and prostate carcinoma.